Your browser doesn't support javascript.
loading
Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principle.
Sanchez Gil, Judit; Dubois, Maxime; Neirinckx, Virginie; Lombard, Arnaud; Coppieters, Natacha; D'Arrigo, Paolo; Isci, Damla; Aldenhoff, Therese; Brouwers, Benoit; Lassence, Cédric; Rogister, Bernard; Lebrun, Marielle; Sadzot-Delvaux, Catherine.
Afiliação
  • Sanchez Gil J; Laboratory of Virology and Immunology, GIGA Infection, Inflammation and Immunity (GIGA I3), University of Liège, 4000 Liège, Belgium.
  • Dubois M; Laboratory of Virology and Immunology, GIGA Infection, Inflammation and Immunity (GIGA I3), University of Liège, 4000 Liège, Belgium.
  • Neirinckx V; Laboratory of Nervous System Disorders and Therapy, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium.
  • Lombard A; Laboratory of Nervous System Disorders and Therapy, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium.
  • Coppieters N; Department of Neurosurgery, CHU of Liège, 4000 Liège, Belgium.
  • D'Arrigo P; Laboratory of Nervous System Disorders and Therapy, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium.
  • Isci D; Laboratory of Virology and Immunology, GIGA Infection, Inflammation and Immunity (GIGA I3), University of Liège, 4000 Liège, Belgium.
  • Aldenhoff T; Laboratory of Nervous System Disorders and Therapy, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium.
  • Brouwers B; Laboratory of Nervous System Disorders and Therapy, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium.
  • Lassence C; Laboratory of Nervous System Disorders and Therapy, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium.
  • Rogister B; Laboratory of Virology and Immunology, GIGA Infection, Inflammation and Immunity (GIGA I3), University of Liège, 4000 Liège, Belgium.
  • Lebrun M; Laboratory of Nervous System Disorders and Therapy, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium.
  • Sadzot-Delvaux C; Department of Neurology, CHU of Liège, 4000 Liège, Belgium.
Mol Ther Oncolytics ; 26: 35-48, 2022 Sep 15.
Article em En | MEDLINE | ID: mdl-35784400
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2022 Tipo de documento: Article